Jellagen
Manufacturing · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Capital Business Park Pkwy, Cardiff, Sou...Phone Number
+44 3333583299Website
www.jellagen.co.ukRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
1
1
1
About Jellagen
Jellagen specializes in collagen-based innovations that cater to complex tissue engineering and regenerative medical needs, aiming to advance next-generation medical treatments. Their flagship product, Collagen Type 0, is a versatile biomaterial derived from jellyfish, making it suitable for various applications such as wound repair, bone repair, and cartilage repair. The company emphasizes ethical sourcing and environmental consciousness in its raw materials, ensuring compatibility with a broad range of cell types. Jellagen's solutions are supported by scientific data, making them a reliable choice for current and future scientific research.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Jellagen your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Jellagen recently announced quarterly report
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Jellagen
Check out if Jellagen is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Jellagen has new funding data
Product Launch: Get notified when Jellagen launches new products
Check if Jellagen has recently received funding, and reach out quickly before it becomes old news!
Click to see if Jellagen had a recent Job posting/layoffs
Jellagen, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Jellagen as Masked Content
Find 3 more new buyers
Compare Similar Companies to Jellagen
Compare insights from companies similar to Jellagen, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Jellagen
<$5M
11-50
Private
$19.1M
2015
N/A
Company Profile Activity
Activity Insights
Jellagen is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Jellagen is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Jellagen.
Jellagen financials insights
Gather financial insights about Jellagen, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Grant
$140K
2016
Private Equity
$2.2M
2018
Other Financing Round
$3.8M
2020
Angel/Seed
$2.4M
2022
Series A
$10.6M
Jellagen Tech Stack
A closer look at the technologies used by Jellagen
See more technologies
Most Recent Scoops
Event
will be attending the Advanced Therapies Week conference as an exhibitor. The event will occur from January 17 to January 20, 2023.
Funding
Funding
Funding
Jellagen News & Media
Jellagen Closes £8.7M Series A Funding
Jallagen, a Cardiff, Wales, UK-based biotech company, raised £8.7M in Series A funding. The round was led by Cardiff Capital Region, Development Bank of Wales, and Thai Union Group PCL. The company intends to use the funds to accelerate the medical development of Collagen Type 0, an innovative and sustainable collagen biomaterial, and advance its […] The post Jellagen Closes £8.7M Series A Funding appeared first on FinSMEs.Cellaria Inc. Launches New Portfolio of Products for Modeling the Tumor Microenvironment and Patient-Specific Preclinical Drug Screening
WAKEFIELD, Mass.--(BUSINESS WIRE)-- #3DModels--Cellaria's new 3D tools offer reproducible, scalable methods for high-throughput studies of in-vitro “avatar” patient populations for drug screeningJellagen® Ltd annonce une collaboration avec Mayo Clinic
CARDIFF, Pays de Galles--(BUSINESS WIRE)--Jellagen® Limited, une entreprise de biotechnologie marine qui fabrique du collagène de grande valeur dérivé de méduses, a conclu un accord de licence pour l'octroi exclusif de droits de brevet avec Mayo Clinic pour le développement dans le traitement de la paralysie des cordes vocales. La paralysie des cordes vocales (PCV) est une lésion d'un ou des deux nerfs laryngés récurrents (NLR), qui contrôlent la plupart des muscles du larynx. IlJellagen® Ltd Jellagen® Ltd kündigt Zusammenarbeit mit Mayo Clinic an
CARDIFF, Wales--(BUSINESS WIRE)--Jellagen® Limited, ein Unternehmen aus dem Bereich marine Biotechnologie, das hochwertiges, aus Quallen gewonnenes Kollagen herstellt, hat mit Mayo Clinic eine Lizenzvereinbarung über die exklusive Vergabe von Patentrechten für Entwicklungaktivitäten zur Behandlung von Stimmbandlähmung abgeschlossen. Stimmbandlähmung [Vocal Cord Paralysis, VCP) ist eine Verletzung eines oder beider rezidivierender Kehlkopfnerven (Recurrent Laryngeal Nerves, RLN), die die meisten
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Jellagen
Sign Up For FreeTo access detailed company insights
Jellagen specializes in collagen-based innovations that cater to complex tissue engineering and regenerative medical needs, aiming to advance next-generation medical treatments. Their flagship product, Collagen Type 0, is a versatile biomaterial derived from jellyfish, making it suitable for various applications such as wound repair, bone repair, a... Read More
